Nonrandom chromosomal changes in transitional cell carcinoma of the bladder

Area of Science:

• Urology
• Cytogenetics
• Oncology

Background:

• Transitional cell carcinoma (TCC) is a significant malignancy affecting the urinary tract.
• Understanding the cytogenetic landscape of TCC is crucial for diagnosing and treating the disease.
• Previous studies have identified various chromosomal abnormalities in TCC, but their specific roles remain under investigation.

Purpose of the Study:

• To perform detailed cytogenetic analysis on nine cases of transitional cell carcinoma (TCC).
• To identify nonrandom chromosomal aberrations and their potential significance in TCC development and progression.
• To investigate the role of specific chromosomal changes, particularly involving chromosome 11, in tumor invasiveness.

Main Methods:

• G-banding cytogenetic analysis was performed on nine TCC samples (eight urinary bladder, one ureter).
• Chromosome synchronization using methotrexate or prolonged Colcemid exposure was employed for high-resolution banding.
• Karyotype analysis was conducted to identify numerical and structural chromosomal abnormalities.

Main Results:

• Six near-diploid, two near-tetraploid, and one hypotriploid karyotype were observed.
• Nonrandom chromosomal aberrations included isochromosome 5p (i(5p)) in three cases and monosomy 9 in four cases, potentially representing primary changes.
• Secondary karyotypic evolution involved chromosomes 8 and 13. Deletions of 11p, possibly linked to an oncogene, were observed in invasive tumors and one noninvasive ureter TCC, suggesting a role in invasiveness.

Conclusions:

• Isochromosome 5p and monosomy 9 are likely primary cytogenetic events in specific subgroups of transitional cell carcinoma.
• Involvement of chromosomes 8 and 13 appears to be part of secondary karyotypic evolution.
• Loss of genetic material from the short arm of chromosome 11 (11p deletion) is a secondary event associated with the invasive behavior of transitional cell carcinoma.